The Week at a Glance
Week 24 was a reminder that when rates come down, dealmakers don’t just talk about doing deals — they do them. Disclosed volume jumped to €3.47bn, driven by a marquee healthcare take-private and a chunky UK wealth platform exit that screams “platform + add-ons” all over again.
The other tell: capital kept flowing to infrastructure-adjacent and security-adjacent software — not the frothy “growth at any price” stuff, but the “mission-critical, regulators-and-procurement-won’t-let-you-switch” stuff. And Italy? Still consolidating like it’s a competitive sport.
If you’re a PE partner looking for a Week 24 takeaway: the market is rewarding cash-flow durability, regulated distribution, and assets that help customers survive energy transition + geopolitical anxiety.
What's Moving the Market
Central bank cuts are finally doing what everyone promised they would: narrowing the bid-ask spread. With the ECB and BoE easing and another 50–100 bps pencilled in by year-end, leverage math is improving just enough to get stalled processes moving — especially in financial services and software, where recurring revenue can underwrite higher entry multiples.
But the vibe isn’t “spray and pray.” Dry powder is moderating, so ICs are acting like adults: fewer speculative bets, more conviction deals with clear paths to cash conversion. That’s why Week 24’s action skewed toward (1) scaled healthcare assets with pricing power and (2) platforms in wealth/asset finance where distribution moats matter.
Meanwhile, rising defence and security budgets keep bleeding into tech allocation. It’s not all tanks and missiles — it’s the software layer: drones, comms, logistics, and “secure-by-default” infrastructure. Expect that theme to keep pushing mid-market valuations up, especially where procurement cycles are already understood.
Deal of the Week
TA Associates’ agreement to acquire UK-based Advanced Medical Solutions for €975.9m is the Week 24 deal that sets the tone: pay up for resilient end-markets, then professionalise and compound.
The interesting part isn’t the headline number — it’s the message. Healthcare “tools and consumables” assets tend to sit in the sweet spot of PE underwriting: less binary than biotech, more defensible than many device categories, and usually supported by sticky clinical workflows. In a market still debating whether 2026 is “soft landing” or “slow recession,” that’s exactly the kind of earnings profile that clears IC.
This also fits the broader playbook we’ve seen from large-cap sponsors moving down into “mid-large” situations: buy a category leader, use operational excellence to widen margins, and bolt on complementary SKUs/distribution. If debt keeps getting cheaper, expect more of these scaled UK healthcare situations to come to market.
The real question for the rest of us: does this reset seller expectations in UK healthcare, or is it a one-off for a uniquely high-quality asset?
UK Money Machines: Platforms, Lenders, and the New Deal Plumbing
Week 24’s financial services tape reads like a blueprint for where mid-market deal activity remains easiest to finance: asset-backed models, advice platforms, and fintechs with optionality.
Start with the cleanest signal: Schroders selling Benchmark for ~€250m to a consortium led by Hg, TowerBrook, Vitruvian, and Aquiline is classic “platform value + roll-up runway.” Wealth platforms are sticky when they’re embedded in adviser workflows — and sponsors love anything that lets them buy fragmented distribution and standardise economics. That’s why Benchmark attracts a buyer set that can industrialise add-ons.
On the credit side, the sheer size of Propel Finance’s €1.81bn funding raise tells you private capital still wants exposure to real-economy lending — ideally secured, granular, and priced for risk. Even with limited detail, Propel Finance fits the “modern non-bank lender as infrastructure” narrative.
Meanwhile, fintech keeps topping up: Revolut disclosed a €69.44m round (investor TBD), and Firenze raised €6.8m to scale wealth lending — a niche that’s basically “private banking UX for the mass affluent.” Add early-stage capital formation like Passion Capital’s Fund IV at €55m, and you’ve got a full-stack ecosystem: venture seeding tomorrow’s targets while sponsors buy today’s scaled platforms.
The meta: rate cuts + private credit expansion are making it easier to fund these models, but selectivity is rising. Expect underwriting to focus on credit quality, origination efficiency, and compliance maturity — not just app downloads.
Europe Re-Arms (and Re-Wires): Defence-Adjacent Tech Meets Energy Transition
Week 24 also showed how “defence budgets up” translates into mid-market deal flow: not necessarily prime contractors, but the enabling infrastructure.
On the defence-adjacent software side, AirHub raised €4.4m for drone operations software aimed at security and defence use cases — exactly the kind of mission-critical layer that benefits from procurement tailwinds and a growing need for interoperability. Similarly, Narwhal Labs pulled in €24.1m for autonomous communications. In a world where resilience matters, comms and command-and-control tooling becomes a budget line item, not an experiment.
Then there’s the “sovereign capability” strand. France-based UNIVITY raised €27m to build sovereign space connectivity for telecom operators, and Germany’s ATMOS Space Cargo closed a €25.7m Series A in space logistics with a broad syndicate including the European Innovation Council. Whether you call it strategic autonomy or just “we don’t want single points of failure,” Europe is clearly funding redundancy.
Overlay energy transition, and you get practical infrastructure plays like Decade Energy raising €22m to scale depot power for commercial vehicles — the unglamorous capex that actually enables fleet electrification. If you’re hunting mid-market angles, this is where “picks-and-shovels” meets policy momentum.
Bottom line: defence and energy themes are converging around resilient infrastructure — digital and physical — and capital is following.
By the Numbers
- 29 deals tracked in Week 24 (+26% vs 4-week avg) — activity broad-based, not just one mega-print.
- €3,467m disclosed volume (+151% vs 4-week avg) — driven by Advanced Medical Solutions (€975.9m) and Benchmark (~€250m), plus the outsized funding at Propel Finance (€1.81bn).
- 19/29 deals disclosed amounts — decent transparency for mid-market, though still plenty of “terms not disclosed” (aka: someone’s trying to keep comps clean).
- Deal types: 17 funding, 11 acquisitions, 1 exit — capital formation still outpacing control deals, but acquisitions are keeping up.
- Top countries: UK (11) and Italy (8) led — the UK dominated financial services/healthcare, while Italy kept stacking industrial and transport consolidation.
- Top sectors: Other (8) remains the catch-all bucket, but Financial Services (6) and Technology (5) show where financing conditions are unlocking activity.
On Our Radar
Two things to watch heading into Week 25. First: Italy’s consolidation machine isn’t slowing — between CTS, Schiaffini Travel, Luilor, and Sistemi Hardware & Software, sponsors and strategics are clearly competing for defensible niches. Who runs out of add-ons first — and who overpays to avoid it?
Second: the market is getting comfortable funding “security + sovereignty” narratives. If AirHub and UNIVITY are early indicators, expect more mid-market processes where the diligence focus shifts from TAM slides to procurement credibility and regulatory clearance.